Skip to content
PARTICIPER À UNE ÉTUDELISTE DE DIFFUSION
X page opens in new window
AB SCIENCE
Discipline serving the patients
AB SCIENCE
  • Home
  • Company
    • Corporate Overview
    • Executive Commitee
    • Scientific Committee
    • Values
  • Science
    • Overview
    • Masitinib in sickle cell disease
    • Masitinib in neurodegenerative disorders
    • AB8939 in oncology
    • Publications
  • Pipeline
    • Pipeline Overview
    • Masitinib
      • Multiple Sclerosis
      • Amyotrophic Lateral Sclerosis
      • Sickle Cell Disease
      • Alzheimer’s Disease
    • AB8939
  • News and Media
    • Press releases
    • In the Media
    • Webcasts
  • Investors
    • Why invest in AB Science
    • Investor Kit
    • Regulated information
      • Annual reports
      • Half-year reports
      • Social and environmental responsabilities
      • Shareholders General Meeting
      • Outstanding shares and voting rights
      • Regulated agreements
      • Articles of Incorporation
      • Board of Directors Charter
      • Information document
    • Stock Information
      • General Information
      • Analyst Coverage
    • Financial Calendar
  • Masivet®
    • About Masivet®
    • Medical information and Pharmacovigilance
  • Careers
  • Contact
  • EN
Search:
  • Home
  • Company
    • Corporate Overview
    • Executive Commitee
    • Scientific Committee
    • Values
  • Science
    • Overview
    • Masitinib in sickle cell disease
    • Masitinib in neurodegenerative disorders
    • AB8939 in oncology
    • Publications
  • Pipeline
    • Pipeline Overview
    • Masitinib
      • Multiple Sclerosis
      • Amyotrophic Lateral Sclerosis
      • Sickle Cell Disease
      • Alzheimer’s Disease
    • AB8939
  • News and Media
    • Press releases
    • In the Media
    • Webcasts
  • Investors
    • Why invest in AB Science
    • Investor Kit
    • Regulated information
      • Annual reports
      • Half-year reports
      • Social and environmental responsabilities
      • Shareholders General Meeting
      • Outstanding shares and voting rights
      • Regulated agreements
      • Articles of Incorporation
      • Board of Directors Charter
      • Information document
    • Stock Information
      • General Information
      • Analyst Coverage
    • Financial Calendar
  • Masivet®
    • About Masivet®
    • Medical information and Pharmacovigilance
  • Careers
  • Contact

Category Archives: Monthly disclosure of total outstanding shares and voting rights

You are here:
  1. Home
  2. Category "Monthly disclosure of total outstanding shares and voting rights"

2017

Monthly disclosure of total outstanding shares and voting rightsBy Alexis BERNARD30 April 2020

Monthly disclosure of total outstanding shares and voting rights Dated December 4, 2017 Monthly disclosure of total outstanding shares and voting rights Dated November 7, 2017 Monthly disclosure of total outstanding shares and voting rights Dated October 2, 2017 Monthly disclosure of total outstanding shares and voting rights Dated August 7, 2017 Monthly disclosure of…

2018

Monthly disclosure of total outstanding shares and voting rightsBy Alexis BERNARD30 April 2020

Monthly disclosure of total outstanding shares and voting rights Dated December 6, 2018 Monthly disclosure of total outstanding shares and voting rights Dated November 6, 2018 Monthly disclosure of total outstanding shares and voting rights Dated October 3, 2018 Monthly disclosure of total outstanding shares and voting rights Dated September 5, 2018 Monthly disclosure of…

2019

Monthly disclosure of total outstanding shares and voting rightsBy Alexis BERNARD30 April 2020

Monthly disclosure of total outstanding shares and voting rights Dated December 2, 2019 Monthly disclosure of total outstanding shares and voting rights Dated November 5, 2019 Monthly disclosure of total outstanding shares and voting rights Dated October 2, 2019 Monthly disclosure of total outstanding shares and voting rights Dated September 3, 2019 Monthly disclosure of…

2020

Monthly disclosure of total outstanding shares and voting rightsBy Alexis BERNARD30 April 2020

Monthly disclosure of total outstanding shares and voting rights Dated April 2, 2020 Monthly disclosure of total outstanding shares and voting rights Dated March 4, 2020 Monthly disclosure of total outstanding shares and voting rights Dated February 5, 2020 Monthly disclosure of total outstanding shares and voting rights Dated January 8, 2020

© 2026 AB SCIENCE
Go to Top